Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus 0.03% vs fluticasone 0.005% in paediatric moderate to severe atopic dermatitis
2004-002478-47Phase 4Completed
- Sponsor
- Fujisawa Pharmaceutical
- Start
- Feb 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Tacrolimus 0.03% ointment arm with Fluticasone 0.005% ointment arm (2 arms). Primary endpoint: Primary mEASI response at week 3. Started Feb 2005; status: completed.
02
Drugs
Envarsus XRfluticasone propionate
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2004-002478-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002478-47.